MedTrace Logo

Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLD

NCT02124577 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-05-06

No results posted yet for this study

Summary

This is a small preliminary study conducted to explore new methods for the potential of aiding in diagnosis of liver fibrotic disease as well as predicting disease progression. There will be a total of 4 visits spread out over approximately 8 weeks. You will be asked to drink "heavy water" during most of that time. "Heavy Water" also known as deuterated water, is physically and chemically very similar to ordinary drinking water. It tastes and feels exactly like regular water. It is odorless and has no known harmful effects at the doses given here. Heavy water occurs naturally, and is a minor component of the water we all ingest daily.

Conditions

  • Non-alcoholic Fatty Liver Disease

Sponsors & Collaborators

Principal Investigators

  • Rohit Loomba, MD · University of California, San Diego

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02124577 on ClinicalTrials.gov